Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01843413 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
A Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor, sponsored by Case Comprehensive Cancer Center.
- Active
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT01843413 is a Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 33 participants, below the 106-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01843413, a Phase 1 study of Tumors Metastatic to Brain and Unspecified Adult Solid Tumor, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I/II trial studies the side effects and the best dose of stereotactic radiosurgery and to see how well it works in treating patients with large brain metastases. Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE cognitive assessment
- RADIATION stereotactic radiosurgery
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-07-02 |
| Est. Completion | 2025-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01843413
The ClinicalTrials.gov registry entry for NCT01843413 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (69% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tumors Metastatic to Brain appearing as the primary indexed condition, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT01843413 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01843413 about?
NCT01843413 is a clinical study titled "Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases". This phase I/II trial studies the side effects and the best dose of stereotactic radiosurgery and to see how well it works in treating patients with large brain metastases. Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT01843413?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2013-07-02. Estimated completion is 2025-08.
What conditions does trial NCT01843413 study?
This clinical trial studies the following conditions: Tumors Metastatic to Brain, Unspecified Adult Solid Tumor.
What interventions are being tested in trial NCT01843413?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), cognitive assessment (PROCEDURE), stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT01843413?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01843413 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors Metastatic to Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
RECRUITING · Phase 1
-
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
COMPLETED · Phase 1
-
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
COMPLETED · Phase 2
-
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.